Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma
Aging · 2023
DOI: 10.18632/aging.204774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Yong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, Chi…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Zitieren
APA
Zhang, Y., Cheng, F., Ma, J., Shi, G., & Deng, H. (2023). Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.204774
Vancouver
Zhang Y, Cheng F, Ma J, Shi G, Deng H. Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. Aging. 2023. doi:10.18632/aging.204774
BibTeX
@article{Zhang2023,
author = {Zhang, Yong and Cheng, Fuyi and Ma, Jinhu and Shi, Gang and Deng, Hongxin},
title = {Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204774}
}
EUVIMED